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Becerra R, Román B, Di Carlo MN, Mariangelo JI, Salas M,
Sanchez G, Donoso P, Schinella GR, Vittone L, Wehrens XH,
Mundiña-Weilenmann C, Said M. Reversible redox modifica-
tions of ryanodine receptor ameliorate ventricular arrhythmias in
the ischemic-reperfused heart. Am J Physiol Heart Circ Physiol
311: H713–H724, 2016. First published July 15, 2016;
doi:10.1152/ajpheart.00142.2016.—Previous results from our lab-
oratory showed that phosphorylation of ryanodine receptor 2
(RyR2) by Ca21 calmodulin-dependent kinase II (CaMKII) was a
critical but not the unique event responsible for the production of
reperfusion-induced arrhythmogenesis, suggesting the existence of
other mechanisms cooperating in an additive way to produce these
rhythm alterations. Oxidative stress is a prominent feature of
ischemia/reperfusion injury. Both CaMKII and RyR2 are proteins
susceptible to alteration by redox modifications. This study was
designed to elucidate whether CaMKII and RyR2 redox changes
occur during reperfusion and whether these changes are involved
in the genesis of arrhythmias. Langendorff-perfused hearts from
rats or transgenic mice with genetic ablation of CaMKII phosphor-
ylation site on RyR2 (S2814A) were subjected to ischemia-reper-
fusion in the presence or absence of a free radical scavenger
(mercaptopropionylglycine, MPG) or inhibitors of NADPH oxi-
dase and nitric oxide synthase. Left ventricular contractile param-
eters and monophasic action potentials were recorded. Oxidation
and phosphorylation of CaMKII and RyR2 were assessed. In-
creased oxidation of CaMKII during reperfusion had no conse-
quences on the level of RyR2 phosphorylation. Avoiding the
reperfusion-induced thiol oxidation of RyR2 with MPG produced
a reduction in the number of arrhythmias and did not modify the
contractile recovery. Conversely, selective prevention of S-nitrosy-
lation and S-glutathionylation of RyR2 was associated with higher
numbers of arrhythmias and impaired contractility. In S2814A
mice, treatment with MPG further reduced the incidence of ar-
rhythmias. Taken together, the results suggest that redox modifi-
cation of RyR2 synergistically with CaMKII phosphorylation mod-
ulates reperfusion arrhythmias.
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NEW & NOTEWORTHY
This study demonstrates that redox changes of ryanodine re-
ceptor type 2 occur together with Ca21 calmodulin-dependent
kinase II phosphorylation of the sarcoplasmic reticulum Ca21
channel in hearts subjected to ischemia/reperfusion. Both post-
translational modifications seem to act synergistically in deter-
mining reperfusion arrhythmogenesis.
RESTORATION OF CORONARY FLOW after a myocardial ischemic
event rescues the heart from further damage. However, reper-
fusion creates a pathophysiological scenario of its own. A
contractile dysfunction and myocyte cell death are pathological
manifestations of the reperfusion injury, which depend on the
duration of ischemia. Even after a brief period of ischemia,
which causes no or little tissue damage, life-threatening ven-
tricular arrhythmias can occur (54). Several clinical reports
have referred to the presence of arrhythmias during the relief of
coronary artery spasm, exercise-induced ischemia, and silent
ischemia or after thrombolysis subsequent to acute myocardial
infarction (30, 37, 41).
During reperfusion, a great part of the arrhythmic events is
thought to be related to an imbalance in ionic currents favoring
a depolarizing net inward current (triggered arrhythmias) (3).
Early afterdepolarizations occur during the action potential
(AP), usually in the setting of prolonged repolarization, and are
classically attributed to reactivation of L-type Ca21 current
(ICa) (20, 32). Delayed afterdepolarizations (DADs) occur after
completion of AP repolarization and are a consequence of
spontaneous sarcoplasmic reticulum (SR) Ca21 release and
activation of a transient inward current (Iti), primarily mediated
by the Na1/Ca21 exchanger (36). This initial stimulus of
nonreentrant nature may give rise to episodes of ventricular
tachycardia or fibrillation. Previous results from our laboratory
showed that, during the early reperfusion of stunned heart,
most of the ventricular premature beats (VPBs) detected were
triggered by DADs and, as expected, decreased when the SR
function was disabled (40). These reperfusion-induced arrhyth-
mias were diminished by 70% in the presence of a Ca21/
calmodulin-dependent protein kinase II (CaMKII) inhibitor
and were reduced by 50% in mice lacking the CaMKII phos-
phorylation site on the ryanodine receptor (RyR2) (40). These
results provided compelling evidence for a critical role of
CaMKII target proteins, particularly RyR2, in reperfusion
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arrhythmogenesis. They also suggest that other mechanisms
cooperate in an additive way to these rhythm alterations.
Reperfusion after ischemia is a condition of oxidative stress in
which reactive oxygen and nitrogen species (ROS/RNS) are
generated by several different cellular sources, which include
the mitochondria, NADPH oxidase (NOX), xanthine oxidase
(XO), and nitric oxide synthase (NOS). Redox modifications of
both CaMKII and RyR2 have been described in different
cardiac diseases, such as heart failure and diabetes (9, 13, 18,
23). However, these changes have been poorly studied in the
ischemic heart injury (2).
Oxidation and autophosphorylation of CaMKII are post-
translational modifications resulting in autonomous activation
of the enzyme (10). Redox-dependent CaMKII activation has
been found to be related to angiotensin II and aldosterone-
induced apoptosis (10, 17, 49), electrical remodeling (51),
sinus node dysfunction (46), and cardiac glycoside treatment
(19), all situations in the course of which life-threatening
arrhythmias can occur. Moreover, oxidized CaMKII has been
reported to be enhanced in atria from patients with atrial
fibrillation (38). Recently, an NO-dependent mechanism for
myocardial CaMKII activation has been elucidated. Gutierrez
et al. (15) showed that CaMKII activity was enhanced in the
presence of NO donors, and Curran et al. (5) extended these
findings showing S-nitrosylation of CaMKII in response to
b-adrenergic stimulation. These studies reported that the in-
creased NO-dependent CaMKII activity was associated with an
increased SR Ca21 leak. Both oxidation and nitrosylation of
CaMKII might occur during ischemia/reperfusion. It is still
unknown whether these mechanisms are involved in the acti-
vation of CaMKII, the consequent phosphorylation of RyR2,
and the generation of arrhythmias observed under this patho-
logical condition.
Extensive information in the literature shows that RyR2
possesses cysteine residues highly susceptible to redox modi-
fications, which have remarkable effects on RyR2 function
(18). RyR2 is endogenously S-glutathionylated (43) and S-
nitrosylated (55), being both reversible redox modifications.
Whereas increases in S-glutathionylation enhanced RyR2-me-
diated Ca21 release and decreased RyR2-mediated Ca21 leak
(7, 42), the consequences of S-nitrosylation of RyR2 remain
controversial. It has been reported that decreased S-nitrosyla-
tion of RyR2 through genetic deletion or pharmacological
inhibition of neuronal NOS is able to induce either an increase
or a decrease in spontaneous SR Ca21 release in isolated
cardiomyocytes (6, 12, 52). The conflicting results in these and
other reports (25, 56) suggest that the impact of S-nitrosylation
on RyR2 activity is critically dependent on the underlying cell
conditions. Surprisingly, no evidence has been reported about
the changes in the redox state of RyR2 during myocardial
reperfusion and their possible functional implications. The
present study was designed to elucidate the occurrence of
CaMKII and RyR2 oxidation in isolated rat hearts subjected to
ischemia/reperfusion and their involvement in the genesis of
reperfusion arrhythmias.
METHODS
The experiments were performed on male Wistar rats (200–300 g
body wt) and transgenic mice (25–30 g) with genetic ablation of the
CaMKII site on RyR2 (S2814A) (4), approved by the Institutional
Animal Care and Use Committee (IACUC) of the School of Medicine,
National University of La Plata, Argentina (Nro T05022014) con-
forming to the Guide for the Care and Use of Laboratory Animals
(NIH, 2011).
Ex Vivo Experiments: Langendorff Perfusion and Experimental
Protocol
Animals were anaesthetized by intraperitoneal injection of ket-
amine and zylazine (70 and 5 mg/kg, respectively). The dose was
sufficient to produce a surgical level of anesthesia (loss of pedal
withdrawal reflex) without profoundly affecting the cardiovascular
function. Central thoracotomy and heart excision were performed
immediately after phase III of anesthesia was reached. Isolated rat
hearts were perfused at a constant temperature (37°C), heart rate (4
Hz), and flow (14 ml/min) with bicarbonate buffer solution (BBS)
composed of (in mM): 128.30 NaCl, 4.70 KCl, 1.35 CaCl2, 20.20
NaHCO3, 0.40 NaH2PO4, 1.10 MgSO4, 11.10 glucose, and 0.04
Na2EDTA. This solution was equilibrated with 95% O2-5% CO2 to
give a pH of 7.4, as described (50). Perfusion of the isolated mouse
hearts was modified as follows: heart rate 6 Hz, flow 4 ml/min, and 2.5
mM CaCl2 in the perfusate. The mechanical activity of the hearts was
assessed by introducing into the left ventricle (LV) a latex balloon
connected to a pressure transducer (ADInstruments) and filled with
aqueous solution to achieve an LV end-diastolic pressure (LVEDP) of
;5–10 mmHg. LV contractility was evaluated measuring the devel-
oped pressure (LVDP) and the maximal rate of pressure development
(1dP/dt) (50).
Epicardial monophasic APs. Monophasic APs (MAPs) were ob-
tained by using a silver/silver chloride Ag/AgCl electrode opposed to
the epicardial surface of the free LV wall as previously described (39).
MAP recordings obtained satisfied previously documented criteria of
a stable baseline and triangular MAP morphology, rapid upstroke
phase, and consistent amplitude (21, 39). Although MAP measure-
ments are local, they were always associated with global changes in
contractility. This makes it possible to correlate these electrical events
with biochemical changes measured in the whole ventricle. Quantifi-
cation of VPBs was accomplished by counting the number of extra
MAPs that do not follow the basal heart rhythm. VPBs and ventricular
tachycardia events (VT) were studied during the first 3 min of
reperfusion.
Experimental protocol. After a 10-min stabilization period, rat/
mouse hearts were subjected to 20/15 min of global normothermic
ischemia followed by 30 min of reperfusion with BBS. In previous
experiments, we have shown that this protocol did not produce
irreversible tissue damage (27). When drugs were used, they were
perfused 10 min before the onset of ischemia and during the reper-
fusion period [10 mM apocynin (APO), 100 mM NG-nitro-L-arginine
methyl ester (L-NAME), 2 mM mercaptopropionylglycine (MPG), 1
mM 4,5-dihydroxy-1,3-benzenedisulfonic acid (Tiron), and 10 mM
S-methyl-L-thiocitrulline (SMTC)]. APO, L-NAME, MPG, and
DMSO, used for the dilution of drugs, did not affect basal contractility
and MAP duration at 90% of repolarization (MAPD90) (Table 1). A
group of hearts perfused but not submitted to ischemia/reperfusion
protocol was used as control (Ctrl). For biochemical assays, hearts
were freeze clamped at 1 min of reperfusion (28).
Electrophoresis and Western Blot
Pulverized frozen ventricles were homogenized in four volumes of
the following (in mM): 25 NaF, 300 sucrose, 1 EDTA, 30 KH2PO4
(pH 7.0) plus protease inhibitor cocktail. The homogenate was sedi-
mented at 13,000 g for 10 min, and the supernatant was fractionated
in small aliquots, frozen in liquid N2, and stored at 280°C. Protein
concentration was measured using the Bradford method with bovine
serum albumin as the standard. For immunological detection of
phosphorylated CaMKII (pCaMKII), phospholamban (PLN), phos-
phorylated PLN (pThr17-PLN), and GAPDH, 20–50 mg of homog-
enate protein was electrophoresed per gel lane in 10% acrylamide gels
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according to Porzio and Pearson (11). For immunological detection of
RyR2 and phosphorylated RyR2 (pS2814-RyR2), 100 mg of homog-
enate protein was electrophoresed per gel lane in 3.5–8.0% gradient
acrylamide gels according to Laemmli (11). For immunological de-
tection of the redox state of CaMKII (oxidized CaMKII, ox-CaMKII)
and RyR2 (S-glutathionylation and S-nitrosylation), 50 mg of homog-
enate protein was resuspended in nonreducing loading solution con-
taining 35 mM N-ethylmaleimide (NEM) and separated in 10%
acrylamide (ox-CaMKII) and 3.5–8.0% gradient Tris-acetate (RyR2)
gels under nonreducing conditions (42). Proteins were transferred to
PVDF membranes (Immobilon-P, Millipore). Blots were blocked with
Tris-buffered saline (TBS) (50 mM Tris, 150 mM NaCl, pH 7.4) with
or without the addition of 0.1% Tween (TBST) and 5% skim milk or
albumin, as indicated for each antibody, and then incubated with the
following primary antibodies: ox-CaMKII (Millipore, 1:1,000 in 5%
milk TBST) and Thr286-phosphorylated CaMKII (Abcam, 1:1,000 in
1% albumin TBST), RyR2 (Santa Cruz Biotechnology, 1:5,000 5%
milk TBST), Ser2814-phosphorylated RyR2 (Badrilla, 1:2,500 in
5% milk TBST), Thr17-phosphorylated PLN (Badrilla, 1:2,500 in 5%
milk TBS), PLN (Thermo Fisher Scientific, 1:5,000 in 1% milk TBS),
GAPDH (Millipore, 1:10,000 in 1% milk TBST), anti-glutathione
(GSH) (Virogen, 1:1,000 in 5% albumin TBST), and anti-nitrosocys-
teine (AG-Scientific, 1:1,000 in 5% albumin TBST). The membranes
were incubated with the appropriate horseradish peroxidase-conju-
gated secondary antibody (Santa Cruz Biotechnology, 1:10,000 in 1%
milk TBST) and developed using an enhanced chemiluminescence
reagent (Millipore). The signals emitted for chemiluminescence were
detected using Chemidoc Imaging system (Bio-Rad) and analyzed
with ImageJ software (NIH). The results were normalized to corre-
sponding densitometry signal of unphosphorylated protein or
GAPDH.
Determination of NOX Activity
Superoxide production was measured by lucigenin chemilumines-
cence in SR vesicles. Microsomal fractions enriched in SR vesicles
were obtained from frozen hearts homogenized in four volumes of 20
mM MOPS-Tris (pH 6.8) and 300 mM sucrose with protease inhib-
itors (4 mg/ml leupeptin, 4 mg/ml pepstatin A, 1 mM benzamidine,
and 1 mM PMSF). The homogenate was sedimented at 3,800 g for 15
min, and the resulting pellet was rehomogenized as above. The
combined supernatants were sedimented at 28,000 g for 15 min. The
resulting supernatant was sedimented at 120,000 g for 1 h after
addition of solid KCl to a final concentration of 0.65 M. The pellet
was resuspended at 10 mg protein/ml in homogenization buffer,
fractionated in small aliquots, frozen in liquid N2, and stored at
280°C. SR vesicles (0.2 mg/ml) were incubated in 100 mM MOPS-
Tris (pH 7.0), 100 mM NADPH, and 5 mM lucigenin at 25°C.
Chemiluminescence was measured in a Berthold FB 12 luminometer
and expressed as nanomoles of superoxide anion per milligram of
protein per minute (42).
Assessment of Reduced GSH Levels
Total reduced GSH content was determined according to Ellman’s
method (44). Briefly, pulverized frozen ventricles were treated with
four volumes of 10% tricarboxylic acid, placed in an ice water bath for
at least 20 min, and then sedimented at 8,500 g for 15 min. The
determination of GSH levels in the supernatant was based on the
reaction of nonprotein sulfhydryl groups with 5,5=dithiobis 2-nitro-
benzoic acid (0.01 M) in 0.4 M Tris buffer pH 8.9 to give a compound
that absorbs at 412 nm. GSH levels were expressed as micrograms per
gram of tissue.
Detection of ROS Production
ROS generation was determined using dihydroethidium (DHE,
Sigma) fluorescence method. DHE produces red fluorescence when
oxidized to ethidium bromide, which is then intercalated into DNA.
Fresh heart sections were frozen in Tissue Tec optimal cutting
temperature compound (Sakura Finetek Europe). With the use of a
Leica cryostat, 20-mm transverse sections were cut, mounted on slides
(Pearl), and incubated with 10 mM DHE at 37°C for 30 min in a
light-protected and humidified chamber. Sections were washed twice
with BBS and stored in the dark. Images were acquired using an
epifluorescence microscope (Nikon Eclipse E200) with rhodamine
filter. The fluorescence intensity per image was quantified using
ImageJ analysis software (NIH). Five frozen cardiac sections per
animal were analyzed, and 20 photographs were randomly taken for
each section with a 340 objective (26).
RyR2 Free Thiol Content
The content of free thiols in RyR2 was determined using the
monobromobimane (mBB, Calbiochem) fluorescence method.
Briefly, frozen heart tissue was homogenized in five volumes HEN
buffer containing 250 mM Hepes (pH 7.4), 1 mM EDTA, 50 mM
neocuproine, 300 mM sucrose, and protease inhibitors (0.5 mg/ml
leupeptin, 1.0 mg/ml pepstatin, 1.0 mM phenylmethylsulfonyl
fluoride, 1.0 mM benzamidine, and protease inhibitor cocktail).
Homogenates were centrifuged at 12,000 g for 10 min, and
supernatants were incubated with 4 mM NEM, 10 mM dithiothre-
itol (DTT) or untreated for 30 min in the dark and at room
temperature. Samples were then centrifuged at 40,000 g for 1 h,
and pellets were washed and resuspended in HEN buffer. Incuba-
tion with 5 mM mBB was performed for 1 h in the dark and at room
temperature. To remove unbound mBB, samples were centrifuged
at 40,000 g for 1 h, and the pellets were washed, resuspended in
HEN buffer, and combined with nonreducing loading buffer with a
final concentration of 2 mM NEM. Samples were heated for 20 min
at 50°C, and proteins were separated in 3.5– 8.0% Tris-acetate gels
under nonreducing conditions. Images were acquired using Chemi-
doc Imaging system (Bio-Rad) and analyzed with ImageJ software
(NIH). mBB fluorescence was normalized to RyR2 amount deter-
mined using Coomassie blue staining of the gels (12, 47). Treat-
ment with reducing (DTT) and oxidizing (NEM) agents was used
to obtain maximum and minimum mBB fluorescence values, re-
spectively, for each intervention.
Statistics
Data are expressed as means 6 SE. Statistical significance was
determined by Student’s t-test for paired or unpaired observations as
appropriate and ANOVA when different groups were compared. The
Newman-Keuls test was used to examine statistical differences ob-
served with the ANOVA. Numbers of arrhythmias between two
different groups were analyzed using the Mann-Whitney test. Values
of P , 0.05 were considered significant.
Table 1. Effects of MPG, APO, and L-NAME on basal
contractility, relaxation, and MAP duration
LVDP,
mmHg 1dP/dt, mmHg/s t1/2, ms
MAPD90,
ms
Control 84.6 6 7.4 2761.36 238.5 48.8 6 1.9 51.86 5.8
MPG (n 5 8) 92.7 6 12.3 2560.06 144.8 54.6 6 2.8 52.56 2.8
Control 88.8 6 3.3 2696.66 128.3 48.4 6 0.8 50.66 6.9
APO (n 5 6) 90.1 6 5.6 2686.76 155.9 53.9 6 2.2 55.86 0.7
Control 96.2 6 8.0 3340.36 243.5 49.8 6 3.9 56.06 1.5
L-NAME (n 5 9) 97.5 6 6.0 3389.76 203.4 55.8 6 5.3 57.06 0.6
Values are means 6 SE and were obtained at the end of the stabilization
(Control) and at the end of the 10-min period of drug perfusion, prior to
ischemia. LVDP, left ventricular developed pressure; 1dP/dt, maximal rate of
pressure development; t1/2, half relaxation time; MAPD90, monophasic action
potential duration at 90% repolarization; MPG, mercaptopropionylglycine;
APO, apocynin; L-NAME, NG-nitro-L-arginine methyl ester.
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RESULTS
Oxidation of CaMKII During Ischemia/Reperfusion
Oxidative stress is a hallmark feature of reperfusion injury,
and CaMKII is directly modified by ROS. Therefore, we
examined the possible involvement of oxidation-dependent
activation of CaMKII in rat hearts subjected to ex vivo isch-
emia/reperfusion. Oxidation of CaMKII (ox-CaMKII) in-
creased by 36% at the beginning of reperfusion. This enhance-
ment was only abrogated by the free radical scavenger MPG.
Neither the NOX inhibitor, APO, nor the general NOS inhib-
itor (L-NAME) was able to reduce the reperfusion-induced
increase in ox-CaMKII (Fig. 1, A and B). To determine the
effect of ox-CaMKII, we studied the phosphorylation of three
CaMKII targets: the kinase itself, PLN, and RyR2 in the
absence and the presence of the different antioxidant treat-
ments (Fig. 1, A–E). The reduction in ox-CaMKII induced by
MPG was not associated with a diminished phosphorylation
level of CaMKII, Thr17 of PLN, and Ser2815 of RyR2. As
expected, the inhibition of NOX and NOS by APO and L-
NAME, respectively, did not modify the phosphorylation of
CaMKII targets. The use of another free radical scavenger,
Tiron, mimicked the effects of MPG on reperfusion-induced
ox-CaMKII levels and autophosphorylation of CaMKII.
Whereas Tiron significantly reduced ox-CaMKII from 130.96
6.0% to 114.3 6 2.9% control, no changes in pCaMKII were
observed (260.0 6 25.7% vs. 356.2 6 66.3% control), n 5
5–13. The overall findings suggest that, although ox-CaMKII
increases during early reperfusion, it seems not to be necessary
to sustain CaMKII activity at least toward its SR substrates.
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Fig. 1. Reperfusion-induced increase in Ca21
calmodulin-dependent kinase II (CaMKII)
activity is independent of its oxidation state.
Typical blots (A) and overall results of ex-
periments showing oxidation (ox-CaMKII,
B) and autophosphorylation of CaMKII
(pCaMKII, C) and phosphorylation of its 2
substrates, Thr17 site of phospholamban
(PLN) (D) and Ser2815 of ryanodine recep-
tor 2 (RyR2) (E), at the onset of ischemia/
reperfusion (I/R) in the absence (ND) or
presence of different antioxidants are shown.
Reperfusion-induced increase in ox-CaMKII
was only abolished by mercaptopropionylg-
lycine (MPG) treatment. MPG, apocynin
(APO), or NG-nitro-L-arginine methyl ester
(L-NAME) (LN) were not able to prevent the
CaMKII-dependent increase in protein phos-
phorylations. The data represent means 6
SE (n 5 5–13 hearts). *P , 0.05 with
respect to control values (Ctrl). #P , 0.05
with respect to reperfusion with no drug ND.
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Moreover, the lack of effect of L-NAME on the phosphoryla-
tion of CaMKII and its targets indirectly indicates that the
described activation by S-nitrosylation of CaMKII (5) is not
occurring in our experimental conditions.
Oxidative/Nitrosative Modifications of RyR2 and Their
Impact on Reperfusion Arrhythmias
ROS/RNS signaling plays a role in the regulation of RyR2
channel gating by promoting redox posttranslational modifica-
tions. It has been shown that oxidative stress developed during
the course of different cardiac diseases induces RyR2 SR Ca21
leak, leading to the appearance of arrhythmias. In these exper-
iments, we particularly examined the S-glutathionylation and
S-nitrosylation of the channel in the stunned heart and its
correlation with the presence of arrhythmias. The level of
these two RyR2 posttranslational modifications increased dur-
ing early reperfusion, and these changes were prevented when
the ischemia/reperfusion protocol was performed in the pres-
ence of MPG (Fig. 2, A and B). In addition, MPG decreased the
number of VPBs (Fig. 3, A and B) and diminished the average
duration of VT, a more severe type of arrhythmia (Fig. 3, C and
D), with a tendency to decrease the incidence of these events
(Fig. 3E). Similar results were obtained when MPG was given
only at reperfusion. Overall, these findings are in line with the
widely accepted concept that oxidized RyR2 is prone to ar-
rhythmias.
To determine the relative contribution of S-glutathionylation
and S-nitrosylation to the generation of arrhythmias, the num-
ber of VPBs and the duration and incidence of VTs were
evaluated in the presence of APO and L-NAME. The reperfu-
sion-induced increase in NOX activity (from 2.6 6 0.1 to
4.1 6 0.4 nmol O2·mg protein21·min21, P , 0.05) was
diminished to control values by APO (2.1 6 0.1 nmol O2·mg
protein21·min21). This treatment selectively suppressed the
S-glutathionylation of RyR2 without affecting the level of
S-nitrosylation (Fig. 4, A and B). In addition, L-NAME abol-
ished the S-nitrosylation of RyR2 in the absence of changes in
S-glutathionylation of RyR2 (Fig. 4, A and B). Neither APO
nor L-NAME treatment alleviated arrhythmogenesis. Con-
versely, the number of VPBs significantly increased (Fig. 4C),
whereas VTs episodes showed a trend toward a longer duration
and higher incidence with respect to ischemia/reperfusion
hearts with no intervention (Fig. 4, D and E). Similarly to
L-NAME, treating the hearts with a NOS-1-specific inhibitor,
SMTC, increased the number of VPBs at early reperfusion
(SMTC: 63 6 3; L-NAME: 65 6 6 vs. ND: 45 6 4, n 5 3–8).
Oxidative/Nitrosative Modifications of RyR2 and Their
Impact on Contractile Recovery
Because arrhythmogenic activity during reperfusion has
been linked to SR Ca21 leak, changes in SR Ca21 load and
therefore in contractility could be expected. The contractile
recovery after ischemia was not modified by MPG;1dP/dt and
LVEDP attained levels similar to control hearts reperfused in
the absence of drugs (Fig. 5, A and B). However, both me-
chanical parameters were drastically impaired by APO and
L-NAME; 1dP/dt was significantly reduced, whereas LVEDP
was enhanced (Fig. 5, C and D). Therefore, removing S-
glutathionylation and/or S-nitrosylation of RyR2 by a reducing
agent (MPG) or through selective enzyme inhibitors (APO,
L-NAME) seemed to be associated with different effects on
contractile recovery after ischemia.
Redox Balance During Ischemia/Reperfusion
Depending on the pharmacological tool used to prevent the
S-glutathionylation and S-nitrosylation, beneficial or deleteri-
ous effects on electrical and mechanical activities during rep-
erfusion were observed. To assess whether this discrepancy
originates from a different oxidative environment derived from
the treatment used, reduced GSH levels were measured in
hearts subjected to ischemia/reperfusion in the presence or
absence of MPG, APO, or L-NAME. The level of GSH was
reduced in ischemia/reperfusion hearts, confirming that oxida-
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tive stress is increased by the injury. Treatment with MPG
restored GSH to control levels; however, APO or L-NAME did
not (Fig. 6A), indicating that only MPG was able to prevent the
oxidative stress induced by ischemia/reperfusion. The antiox-
idant effect of MPG was confirmed by quantifying ROS
production using DHE staining. The increased ethidium fluo-
rescence intensity observed in hearts subjected to ischemia/
reperfusion was reduced by MPG treatment (Fig. 6, B and C).
These changes in ROS production were paralleled by changes
in the redox state of RyR2, as determined by the mBB fluo-
rescence method. Ischemia/reperfusion decreased the level of
free thiol content on RyR2, consistent with increased oxidation
of the SR Ca21 channel, and the presence of MPG precluded
this effect (Fig. 6, D and E). Thus the apparent beneficial or
deleterious effects of S-glutathionylation and S-nitrosylation of
RyR2 on the electrical and mechanical activity during reper-
fusion seem to depend on the cellular redox milieu, which is
differentially affected by the three antioxidants used.
Impact of CaMKII-Dependent Phosphorylation and
Oxidation of RyR2 on the Propensity for Reperfusion
Arrhythmias
As we previously described, knockin mice lacking the prin-
cipal CaMKII phosphorylation site in RyR2 (S2814A) showed
a marked decrease in reperfusion arrhythmogenesis (40). To
test whether antioxidant treatment further reduced the appear-
ance of arrhythmias, S2814A mice were subjected to ischemia/
reperfusion in the absence and presence of MPG (Fig. 7).
Reduction of cellular oxidative stress by MPG, which avoids
the oxidation of RyR2 during reperfusion (Fig. 6, D and E),
further diminished the number of VPBs by 50%. These results
give support to the concept that both phosphorylation and
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oxidation of RyR2 are involved in the generation of reperfu-
sion arrhythmias. Furthermore, the results suggest that oxida-
tion of RyR2 contributes to reperfusion arrhythmias, even in
the absence of the CaMKII-dependent phosphorylation of
RyR2.
DISCUSSION
Oxidative stress is a prominent feature in the onset and
progression of a number of heart diseases, including ischemia/
reperfusion injury. It is well known that CaMKII and RyR2 are
functionally influenced by redox modifications (9, 13, 18, 23).
Our results indicate that both proteins become oxidized fol-
lowing ischemia/reperfusion in the intact heart, but the impact
of such alterations on the genesis of arrhythmias and the
recovery of contractility are apparently different. Although
oxidation of CaMKII seems to have no consequences in terms
of the activity of the enzyme and the phosphorylation of two
SR target proteins, the redox modifications of RyR2 appear to
have both beneficial and detrimental effects. In the present
work, we particularly studied the S-glutathionylation and S-
nitrosylation of RyR2, two reversible posttranslational modi-
fications of the channel that seem to play a protective role in
the arrhythmogenesis and the contractile recovery of the
stunned heart.
CaMKII Mechanism of Activation During
Ischemia/Reperfusion
Redox-dependent CaMKII activation alters different mech-
anisms that may contribute to arrhythmia propensity (23). In
postischemic reperfusion, a well-known situation of oxidative
stress, experiments from our laboratory previously demon-
strated that CaMKII-dependent phosphorylation of RyR2 is a
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crucial factor for triggering arrhythmias (40). The present
findings further showed that ox-CaMKII increased during rep-
erfusion by a NOX-uncoupled/NOS-independent mechanism.
In this scenario, mitochondria appear as a good candidate to
provide the ROS involved in CaMKII oxidation. However,
redox-dependent activation of this enzyme did not influence
the degree of RyR2 phosphorylation. The lack of relationship
between oxidation and activation of CaMKII has also been
reported by Bell et al. (2), who showed similar levels of
ox-CaMKII in stunned male and female rat hearts associated
with different phosphorylation extent of CaMKII and PLN.
Taken together, the overall results suggest that ox-CaMKII is
not essential to maintain the kinase activity in ischemia/reper-
fusion at least toward its SR substrates. It is likely that the
massive Ca21 overload at early reperfusion produced by both
an uncontrolled Ca21 influx (34) and SR Ca21 depletion (48)
provides the necessary intracellular Ca21 to activate and sus-
tain CaMKII activity independently of its oxidation state.
Oxidative/Nitrosative Changes of RyR2 and
Arrhythmogenesis During Ischemia/Reperfusion
RyR2 is highly sensitive to redox state attributable to the
large number of cysteines that compose the homo-tetramer
(18). Depending on the degree of oxidative stress, RyR2 free
thiols can be reversibly or irreversibly oxidized (31). Three
types of reversible redox modifications have been described for
RyR2: disulfide oxidation, S-nitrosylation, and S-glutathiony-
lation. Whereas irreversible oxidation unambiguously in-
creases RyR2 activity (31, 45, 53), the impact of reversible
redox changes on the channel function remains controversial
(6, 7, 12, 25, 42, 52, 56). It has been suggested that RyR2
intersubunit cross linking or alterations in RyR2 association
with auxiliary proteins, as a result of oxidative stress, promote
an increase in RyR2 activity and diastolic Ca21 leak (24, 33).
This Ca21 leak could be the cause of the formation of Ca21
waves sufficient to induce spontaneous APs and therefore
cardiac arrhythmias during reperfusion. Among protein redox
modifications, S-nitrosylation and S-glutathionylation have
been proposed to conspire to the redox-induced deleterious
effects by protecting the reactive thiol groups from further
irreversible oxidation (14, 29). In the stunned heart, neither the
occurrence of redox changes of RyR2 nor their functional
consequences on arrhythmias and contractile dysfunction have
been previously described.
In the present study, we found that S-nitrosylation and
S-glutathionylation of RyR2 augmented during early reperfu-
sion after ischemia. Prevention of these reversible redox mod-
ifications in the reperfusion-induced oxidative environment
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was associated with a higher number of arrhythmias and an
impaired contractile recovery. It is likely that, in this context,
S-nitrosylation and S-glutathionylation emerge as protective
mechanisms. Our findings are consistent with Cuttler et al. (6),
who found that the combination of decreased S-nitrosylation
and increased oxidation of RyR2 leads to a striking increase in
spontaneous SR Ca21 release and ventricular arrhythmias, in
intact hearts exposed to elevated [Ca21] and oxidative stress,
two prevailing conditions in ischemia/reperfusion. Similar re-
sults were described in the failing heart (1, 13).
565kDa
565kDa
MPGND
I/RCtrl
RyR2
mBB
DH
E 
m
ea
n 
flu
or
es
ce
nc
e 
(a
.u
.)
0
3
6
9
12
15
18
21
NND M
PG
*
#
0
10
20
30
40
50
60
A
PO
N
D
M
PG
LN
A
M
EG
S
H
 
g/
g 
tis
su
e)
#
* *
*
Ctrl I/R
A
ND MPGCtrl
B C
I/R
D E
m
B
B
/R
yR
 (%
 C
trl
)
0
25
50
75
100
125
*
#
Ctrl I/R
ND M
PG
Ctrl I/R
Fig. 6. Effects of the antioxidants on reduced GSH content, reactive oxygen species (ROS) formation, and RyR2 free thiol content during reperfusion. Average
levels of reduced form of GSH measured in tissue homogenates from Ctrl or I/R rat hearts in the absence (ND) or presence of MPG, APO, or L-NAME are shown.
Only MPG treatment restored GSH levels to Ctrl values (A). Representative images (B) and overall results (C) of dihydroethidium (DHE) staining for ROS
production in Ctrl and I/R hearts without (ND) or with MPG treatment are shown. MPG reduces ROS production to Ctrl levels. Representative
(monobromobimane, mBB) fluorescence intensity and Coomassie blue-stained gels of RyR2 (D) and average results of free thiol content on RyR2 (E) in Ctrl
and I/R hearts in the absence (ND) or presence of MPG are shown. Content of free thiols decreases in I/R, and it is restored by treatment with MPG. The data
represent means 6 SE (n 5 3–6 hearts). *P , 0.05 with respect to Ctrl. #P , 0.05 with respect to reperfusion with ND.
H721REDOX CHANGES OF RYR2 AND REPERFUSION ARRHYTHMIAS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00142.2016 • www.ajpheart.org
Downloaded from www.physiology.org/journal/ajpheart (163.010.034.197) on August 20, 2019.
A different situation occurred when the reperfusion-induced
oxidative stress was precluded by the presence of the free
radical scavenger, MPG. Although the S-nitrosylation and
S-glutathionylation of RyR2 were blunted, the number of
VPBs and the duration of VTs decreased. In this environment,
both the reversible and the irreversible oxidations of RyR2
might be prevented, turning RyR2 into a less leaky channel and
decreasing the severity of arrhythmias. The fact that the con-
tent of free thiols on RyR2 in those hearts subjected to
ischemia/reperfusion in the presence of MPG was similar to
control conditions supports this possibility. The antiarrhythmic
effects of MPG treatment were not associated with an enhance-
ment of the contractile recovery after ischemia. This behavior
might reflect the capacity of myocyte Ca21 handling for
autoregulation (8). Although the SR Ca21 content might be
transiently higher in the presence of MPG, the compensatory
changes in Ca21 fluxes would restore Ca21 cycling and steady-
state contractility after ischemia. However, this mechanism
might be overwhelmed when the severity of reperfusion ar-
rhythmias increased, as in the case of APO and L-NAME. The
lack of reversible oxidations, which turns RyR2 hyperactive as
a result of irreversible oxidation, could lead to a drastic SR
Ca21 leak, which would deplete the SR, decrease Ca21 tran-
sient, and impair contractility.
Several experiments studying the impact of redox changes
on RyR2 activity have been performed in artificial planar
bilayer systems or isolated myocytes (1, 16, 47). The novelty
of the present findings is that we were able to detect reperfu-
sion-induced redox modifications of RyR2 in the intact ex vivo
heart, a model in which the general nitroso/redox balance is
better preserved.
Contribution of Nitroso/Redox Imbalance to
Ischemia/Reperfusion Arrhythmias in S2814A Mice
Numerous studies have shown that either CaMKII-depen-
dent phosphorylation or oxidation of RyR2 favors the genera-
tion of arrhythmias (1, 4). Recently, a potential interaction of
the two posttranslational modifications of RyR2 has been
described in different animal models (6, 22, 53). In the mdx
mouse model of Duchenne muscular dystrophy (22, 53), the
oxidation state and the activity of RyR2 were markedly re-
duced when RyR2 phosphorylation was genetically inhibited.
In contrast, the reduced S-nitrosylation of RyR2 caused by
inhibition of neuronal NOS increased the oxidation of RyR2
and Ca21-triggered arrhythmias in intact guinea pig hearts,
together with a decrease in the phosphorylation of Ser2814 site
of RyR2. A cross talk between ROS/RNS modifications and
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phosphorylation of RyR2 was not evident in the present ex-
periments of hearts subjected to ischemia/reperfusion. Antiox-
idant treatments, which modified the redox state of RyR2,
altered the propensity to arrhythmias, without affecting the
reperfusion-induced increase in CaMKII phosphorylation of
RyR2. Moreover, in mice lacking the CaMKII phosphorylation
site of RyR2, which showed a decreased number of VPBs
compared with wild-type, MPG further reduced the propensity
to arrhythmias. Thus, in our experimental conditions, oxidation
and phosphorylation seem to act as independent and additive
pathways of regulation of RyR2 activity.
In conclusion, our present results provide new insights into
the mechanisms underlying the reperfusion arrhythmias. They
suggest that, whereas S-nitrosylation and S-glutathionylation of
RyR2 restrain the propensity for arrhythmias, other oxidations
of RyR2 amplify the arrhythmogenic effect of the CaMKII
phosphorylation of the channel. These mechanisms, working in
concert, provide the molecular basis for reperfusion arrhyth-
mias, and they must be considered as therapeutic targets in the
ischemia/reperfusion injury.
Limitations of This Study
The present data show that nitroso/redox imbalance is an
important mechanism that contributes to the triggering of
VPBs and VT during the early reperfusion phase and suggest
that RyR2 is a putative player in this scenario. We are aware of
the fact that a causal relationship between RyR2 redox modi-
fication and arrhythmias is difficult to ascertain in the intact
heart in which pharmacological interventions are unlikely to
have effects limited only to RyR2. Alteration of other redox-
sensitive proteins cannot be excluded. In this context, it was
recently reported that SERCA2a oxidation plays a significant
role in repolarization alternans associated with myocardial
infarction (35). Future work is needed to validate the contri-
bution of selective RyR2 redox modifications to reperfusion
arrhythmogenesis.
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